- Home
- INDO vs CING Comparison
INDO vs CING Comparison
Compare INDO & CING Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | INDO | CING |
|---|---|---|
| Founded | 2018 | 2012 |
| Country | Indonesia | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 47.1M | 40.5M |
| IPO Year | 2019 | 2021 |
Fundamental Metrics
Financial Performance| Metric | INDO | CING |
|---|---|---|
| Price | $4.18 | $5.37 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $31.33 |
| AVG Volume (30 Days) | ★ 1.3M | 229.8K |
| Earning Date | 09-30-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $2,293,625.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.10 | $3.20 |
| 52 Week High | $7.95 | $6.74 |
Technical Indicators
Market Signals| Indicator | INDO | CING |
|---|---|---|
| Relative Strength Index (RSI) | 65.38 | 62.79 |
| Support Level | $3.47 | $4.83 |
| Resistance Level | $4.95 | $6.74 |
| Average True Range (ATR) | 0.39 | 0.54 |
| MACD | 0.05 | 0.07 |
| Stochastic Oscillator | 62.68 | 45.16 |
Price Performance
Historical ComparisonAbout INDO Indonesia Energy Corporation Limited
Indonesia Energy Corp Ltd is an oil and gas exploration and production company focused on Indonesia. The company is an independent energy company engaged in the oil and gas business and holds two oil and gas assets through its subsidiaries in Indonesia: The Kruh Block and the Citarum Block. It has also identified a potential third exploration block known as the Rangkas area. . Its portfolio consists of Kruh Block and Citarum Block. The company generates its revenue from oil and gas sales.
About CING Cingulate Inc.
Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates.